Why FDA Approval Matters in Scientific Research FDA approval is viewed as a significant milestone in drug development because it reflects the completion of extensive regulatory review
Another study has reported that treatment of the DPP-4 inhibitor vildagliptin (10 mg/kg) in STZ-induced diabetic rats suppresses plasma TNF- concentrations and inhibits nitric oxide concentrations in the serum (Akarte et al., 2012)
While the evidence is largely based on case reports and physiological rationale rather than large controlled studies, this has led to increased awareness and the development of specific management strategies
Molecular therapy : the journal of the American Society of Gene Therapy, 25(7), 16281640
To be eligible for semaglutide as a weight loss treatment, a person usually needs to have a body mass index (BMI) of 30 or higher, which means they are classified as obese
And as the authors further noted, The therapeutic scope of GLP-1 medicines extends beyond glycemic control and weight loss, with benefits evident in people with atherosclerotic heart disease, heart failure with preserved ejection fraction (HFpEF), peripheral artery disease, diabetic kidney disease, knee osteoarthritis, and obstructive sleep apnea (OSA). However, as the team further pointed out, the mechanisms by which GLP-1 medicines improve organ dysfunction remain incompletely understood. Drucker has been at the forefront of GLP-1 research since the 1980s when his pioneering discoveries helped lay the groundwork for the development of GLP-1 medicines
